Avandia: FDA where are you?

Despite various studies and congressional testimony of experts revealing the risks of heart attack and stroke from the Diabetes drug Avandia, the company is still selling the product and the FDA has not convened to decide on removing it from the market. The real question is why has there been such a delay, given the clarity of the information available concerning the dangers of the drug?